205 results
Tricuspid valve intervention in complex scenarios - Tackling tricuspid regurgitation using a multidisciplinary approach
20 Nov 2023 – From PCR London Valves 2023
This session explores the diverse phenotypes of tricuspid regurgitation patients, emphasizing the clinical implications and advocating for a multidisciplinary approach to assessment and treatment. It covers TR clinical courses, investigation pathways, and case scenarios, including atrial fibrillation, heart failure (preserved and reduced ejection fraction), pulmonary hypertension,...
Expert roundtable: 4D ICE in tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Join this session if you want to get familiar with the 4D ICE technology and the key elements of image guidance for tricuspid interventions, understand how 4D ICE can assist in specific procedural steps during challenging tricuspid interventions, and engage in an interactive discussion with experts...
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
Key questions in tricuspid valve intervention - How do I define treatment options according to individual patient anatomy?
19 Nov 2023 – From PCR London Valves 2023
Explore this tricuspid valve-focused session featuring analysis of four clinical cases: Ebstein anomaly, severe and torrential tricuspid regurgitations, and anterior flail-related torrential regurgitation. Gain insights into optimal treatment selection for each scenario, leveraging pre-procedural imaging for informed decision-making.
Second time TAVI (TAV-in-TAV) - Not as simple as it looks
19 Nov 2023 – From PCR London Valves 2023
Although it is still rare, TAV-in-TAV is likely to become more frequent, as TAVI is increasingly implanted in younger patients. Harmonizing data in this area will therefore help to improve outcomes, the quality of which depends on site experience, bearing in mind that for the time...
Planning and execution of re-do TAVI (TAV-in-TAV) procedures
19 Nov 2023 – From PCR London Valves 2023
Redo TAVI poses challenges but can be managed with a step-by-step procedural plan, ensuring better acute and long-term outcomes. Guidelines and industry resources aid in planning, yet forthcoming registry studies are essential for further data and insights. Watch this session to find out more!
Key questions in mitral valve intervention - Transcatheter edge-to-edge repair (Part 1) - what do I need to know to do the procedure safely?
19 Nov 2023 – From PCR London Valves 2023
Analyze in depth the case of a 64-year-old female patient with ischaemic cardiomyopathy with LVEF 40 % and severe ventricular mitral regurgitation, who previously had NSTE-ACS treated with LAD and circumflex PCI, and who presented with recent worsening heart failure and persistent NYHA class II-III, and...
Key questions in tricuspid valve intervention - What can cardiologists learn from surgeons when choosing to repair or replace the tricuspid valve?
19 Nov 2023 – From PCR London Valves 2023
Watch this session to explore the latest approaches in surgical and transcatheter tricuspid valve repair and replacement. Gain insights into the influence of right ventricular dysfunction and pulmonary hypertension on post-procedural outcomes, and understand the bleeding risks linked to oral anticoagulation in patients with tricuspid valve...
